Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Total Debt / EBITDA

Iovance Biotherapeutics Inc Total Debt / EBITDA Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Total Debt / EBITDA from 2011 to 2020.
  • Iovance Biotherapeutics Inc Total Debt / EBITDA for the quarter ending June 06, 2020 was $0m a -132.83% increase of 0m year over year
  • Iovance Biotherapeutics Inc Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $0m a -162.15% increase of 0m year over year
  • Iovance Biotherapeutics Inc Annual Total Debt / EBITDA for 2019 was $0m a -1,222.00% increase of 1m from 2018
  • Iovance Biotherapeutics Inc Annual Total Debt / EBITDA for 2012 was $-1m a 70.23% decrease of -1m from 2011
  • Iovance Biotherapeutics Inc Annual Total Debt / EBITDA for 2011 was $0m
Other Ratios Metrics:
  • Iovance Biotherapeutics Inc Total Debt / Capital for the quarter ending March 03, 2010 was $3m
  • Iovance Biotherapeutics Inc Other Liabilities for the quarter ending March 03, 2014 was $0m
  • Iovance Biotherapeutics Inc Total Debt / Equity for the quarter ending March 03, 2010 was $4m
View Chart On Koyfin

Quarterly IOVA Total Debt / EBITDA Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
03/2013$-2m
12/2012$-1m
09/2012$-1m
06/2012$-1m

Annual IOVA Total Debt / EBITDA Data

2019$0m
2012$-1m
2011$0m